1 / 9

Point Of Care Diagnostics Market is Set to Boom in 2023

The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others.<br><br>Request sample copy of this report at: https://www.alliedmarketresearch.com/request-sample/161

Download Presentation

Point Of Care Diagnostics Market is Set to Boom in 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Point of Care Diagnostics Market  Global Opportunity Analysis and Industry Forecasts, 2014 - 2022 No. of Pages: 145 Publish: Oct 2016

  2. Point of Care Diagnostics Market  • The glucose monitoring kits is the top investment pocket in the POC testing devices market. This is attributed to its superior performance, innovative, and advanced applications of these kits. Moreover, the increase in adoption rate of glucose monitoring kits and rise in incidences of diabetes and long shelf life of kits would propel the stakeholders to capitalize on the underlying opportunities in this industry. • - Sachin Sinha

  3. Point of Care Diagnostics Market  Overview • Global Point Of Care Diagnostics Marketsize was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. • The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others. • Rising prevalence of various infectious diseases and several initiatives implemented by government and non-government associations for rise in health awareness around the world are the factors majorly driving the point of care diagnostics market growth. • The technological advancements in point of care diagnostic devices, introduction of home-based point of care devices; and increase in healthcare expenditure also support the growth of the global point of care diagnostics market.

  4. Point of Care Diagnostics Market  Key Benefits • The study provides an in-depth analysis of the global industry with current point of care diagnostics market trends and future estimations to elucidate the imminent investment pockets in the market. • The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities. • Extensive analysis of the global point of care diagnostics industry, by product, explains various types of devices used in the diagnosis of various diseases. • Competitive intelligence highlights the business practices followed by leading market players across different geographical regions.

  5. Point of Care Diagnostics Market  Key Findings • In 2015, glucose monitoring kits was the leading segment of overall point of care diagnostics market revenue. • Infectious disease testing kits segment is expected to grow at a remarkable CAGR of 13.1%, owing to increased demand in the diagnosis of infectious diseases. • North America was the leading reginal POC devices market followed by Europe and Asia-Pacific in 2015. • Over-the-counter testing kits segment is projected to grow at a CAGR of 104% during analysis period. • Japan alone is the major shareholder in the Asia-Pacific region accounting for about one-third share of the Asia-Pacific point of care diagnostics market. • Asia-Pacific infectious diseases testing kits market is expected to grow at a CAGR o 14.1% during analysis period.

  6. Point of Care Diagnostics Market  Segments By End Users Mode of Prescription POINT OF CARE DIAGNOSTICS MARKET KEY SEGMENTS By Geography By Product Type

  7. Point of Care Diagnostics Market  By Geography • North America, Europe, Asia-Pacific, LAMEA

  8. Key Players in Industry • Abbott Laboratories • Siemens AG • F. Hoffmann-La Roche Ltd. • Sinocare Inc. • Johnson & Johnson • Sysmex Corporation • Nova Biomedical • Danaher Corporation • Becton Dickinson and Company • bioMrieux SA • Bio-Rad Laboratories • Download Sample Copy of this Report Click Here

  9. Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/point-of-care-diagnostics-market Follow Us On

More Related